We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.6B
AUM Growth
+$48.1M
Cap. Flow
-$19.5M
Cap. Flow %
-0.75%
Top 10 Hldgs %
37.12%
Holding
232
New
10
Increased
45
Reduced
101
Closed
15
Avg Time Held
13.1 quarters
Top 10 Avg Time Held
11.5 quarters
Top 20 Avg Time Held
11.8 quarters

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$22.1M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$14.7M
3
IBM icon
IBM
IBM
+$9.86M
4
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$9.81M
5
ORCL icon
Oracle
ORCL
+$9.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.5M
2
PEP icon
PepsiCo
PEP
+$12.1M
3
GILD icon
Gilead Sciences
GILD
+$9.61M
4
COL
Rockwell Collins
COL
+$4.97M
5
PG icon
Procter & Gamble
PG
+$4.81M

Sector Composition

Rank Sector Weight
1 Industrials 19.66%
2 Financials 16.35%
3 Communication Services 15.88%
4 Healthcare 13.78%
5 Consumer Staples 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KSU
26
DELISTED
Kansas City Southern
KSU
$30.9M 1.19%
284,693
-55
-0% -$5.77K
2013 Q2
17 quarters
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.31T
$30.6M 1.18%
628,880
-13,340
-2% -$633K
2015 Q4
7 quarters
HIG icon
28
Hartford Financial Services
HIG
$35.3B
$30.2M 1.16%
544,393
-6,510
-1% -$354K
2013 Q2
17 quarters
ITW icon
29
Illinois Tool Works
ITW
$75.5B
$30M 1.15%
202,467
-6,393
-3% -$909K
2013 Q2
17 quarters
COL
30
DELISTED
Rockwell Collins
COL
$29.6M 1.14%
226,261
-40,902
-15% -$4.97M
2013 Q2
17 quarters
SAP icon
31
SAP
SAP
$251B
$28.9M 1.11%
263,225
-9,370
-3% -$995K
2014 Q1
14 quarters
MRK icon
32
Merck
MRK
$359B
$28.3M 1.09%
463,133
-6,979
-1% -$423K
2013 Q2
17 quarters
TMO icon
33
Thermo Fisher Scientific
TMO
$245B
$27.8M 1.07%
147,015
-18,228
-11% -$3.3M
2015 Q2
9 quarters
MDT icon
34
Medtronic
MDT
$118B
$27.7M 1.07%
356,122
-15,497
-4% -$1.29M
2013 Q2
17 quarters
LLY icon
35
Eli Lilly
LLY
$1.05T
$27.2M 1.05%
318,540
-1
-0% -$82
2013 Q2
17 quarters
HES icon
36
DELISTED
Hess
HES
$27.2M 1.04%
579,103
-29,091
-5% -$1.23M
2013 Q2
17 quarters
SLB icon
37
SLB Ltd
SLB
$72.4B
$26.6M 1.02%
381,508
-12,918
-3% -$854K
2013 Q2
17 quarters
AMZN icon
38
Amazon
AMZN
$2.8T
$26.4M 1.02%
549,980
-39,320
-7% -$1.93M
2013 Q2
17 quarters
CCI icon
39
Crown Castle
CCI
$34.5B
$26.3M 1.01%
263,097
-6,982
-3% -$714K
2015 Q3
8 quarters
WY icon
40
Weyerhaeuser
WY
$13.7B
$25.4M 0.98%
747,421
-19,535
-3% -$641K
2015 Q3
8 quarters
CELG
41
DELISTED
Celgene Corp
CELG
$25.4M 0.98%
174,098
-6,565
-4% -$894K
2013 Q2
17 quarters
INTC icon
42
Intel
INTC
$536B
$24.5M 0.94%
642,690
+621,069
+2,873% +$22.1M
2013 Q2
17 quarters
NWL icon
43
Newell Brands
NWL
$2.38B
$23.9M 0.92%
558,998
-1,510
-0.3% -$73.8K
2015 Q2
9 quarters
PANW icon
44
Palo Alto Networks
PANW
$330B
$23.6M 0.91%
980,706
+254,346
+35% +$5.79M
2017 Q2
1 quarter
SYF icon
45
Synchrony
SYF
$24B
$22.7M 0.87%
732,061
-11,964
-2% -$358K
2015 Q4
7 quarters
NEM icon
46
Newmont
NEM
$123B
$21.9M 0.84%
583,830
-42,410
-7% -$1.54M
2013 Q2
17 quarters
MET icon
47
MetLife
MET
$63.7B
$21.3M 0.82%
410,352
-36,212
-8% -$1.76M
2013 Q2
17 quarters
YUM icon
48
Yum! Brands
YUM
$40B
$20.8M 0.8%
282,274
-583
-0.2% -$43.9K
2013 Q2
17 quarters
CVS icon
49
CVS Health
CVS
$112B
$20.6M 0.79%
253,904
+1,861
+0.7% +$147K
2013 Q2
17 quarters
GSK icon
50
GSK
GSK
$94B
$19.4M 0.75%
382,513
-3,424
-0.9% -$174K
2013 Q2
17 quarters

Similar funds

Klingenstein Fields & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Klingenstein Fields & Co held 232 positions worth $2.6B, up 1.9% from $2.55B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q3 2017 filing shows 10 new, 45 increased, 101 reduced and 15 closed positions. Its largest new stake was Applied Materials: 11,560 shares worth $602K. The largest sale was Biogen, an estimated $16.5M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 20% a quarter earlier, followed by Financials and Communication Services.

  • Klingenstein Fields & Co's largest Q3 2017 buy was Applied Materials: 11,560 shares worth $602K.
  • Klingenstein Fields & Co added most to Intel in Q3 2017, an estimated $22.1M increase.
  • Klingenstein Fields & Co's biggest Q3 2017 reduction was PepsiCo, cutting an estimated $12.1M.
  • Klingenstein Fields & Co fully exited Biogen in Q3 2017, selling an estimated $16.5M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.6B portfolio in Q3 2017.
  • Klingenstein Fields & Co opened 10 new positions and closed 15 in Q3 2017.
  • Klingenstein Fields & Co's portfolio value rose 1.9% quarter-over-quarter to $2.6B.

Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.